Combining Bevacizumab with Temozolomide Increases the Antitumor Efficacy of Temozolomide in a Human Glioblastoma Orthotopic Xenograft Model

Podobne knjige/članki

• The sodium pump α1 sub-unit: a disease progression–related target for metastatic melanoma treatment
  od: Mathieu, Véronique, et al.
  Izdano: (2009)
• Upfront Bevacizumab and Temozolomide or Fotemustine before Radiotherapy for Patients with Glioblastoma and Severe Neurological Impairment at Diagnosis
  od: Celina Bihan, et al.
  Izdano: (2012-09-01)
• Upfront Bevacizumab and Temozolomide or Fotemustine before Radiotherapy for Patients with Glioblastoma and Severe Neurological Impairment at Diagnosis
  od: Bihan, Celina, et al.
  Izdano: (2012)
• Evaluation of MGMT Promoter Methylation Status and Correlation with Temozolomide Response in Orthotopic Glioblastoma Xenograft Model
  od: Kitange, Gaspar J., et al.
  Izdano: (2008)
• Alisertib demonstrates significant antitumor activity in bevacizumab resistant, patient derived orthotopic models of glioblastoma
  od: Kurokawa, C, et al.
  Izdano: (2016)